nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
ADORA1 Inhibition Promotes Tumor Immune Evasion by Regulating the ATF3-PD-L1 Axis
|
Liu, Hong |
|
|
37 |
3 |
p. 324-339.e8 |
artikel |
2 |
An Integrated Gene Expression Landscape Profiling Approach to Identify Lung Tumor Endothelial Cell Heterogeneity and Angiogenic Candidates
|
Goveia, Jermaine |
|
|
37 |
3 |
p. 421 |
artikel |
3 |
Breaking Down the Barriers to Define and Treat NK/T Cell Lymphoma
|
Mundy-Bosse, Bethany |
|
|
37 |
3 |
p. 263-265 |
artikel |
4 |
CDK4/6 Inhibitors Impair Recovery from Cytotoxic Chemotherapy in Pancreatic Adenocarcinoma
|
Salvador-Barbero, Beatriz |
|
|
37 |
3 |
p. 340-353.e6 |
artikel |
5 |
Chemotherapy and CDK4/6 Inhibition in Cancer Treatment: Timing Is Everything
|
Fassl, Anne |
|
|
37 |
3 |
p. 265-267 |
artikel |
6 |
Context-Dependent Immune Responses Explain Pancreatic Cancer Immunoresistance
|
Bednar, Filip |
|
|
37 |
3 |
p. 261-263 |
artikel |
7 |
Cyto-Immuno-Therapy for Cancer: A Pathway Elicited by Tumor-Targeted, Cytotoxic Drug-Packaged Bacterially Derived Nanocells
|
Sagnella, Sharon M. |
|
|
37 |
3 |
p. 354-370.e7 |
artikel |
8 |
Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer
|
Hegde, Samarth |
|
|
37 |
3 |
p. 289-307.e9 |
artikel |
9 |
Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma
|
Xiong, Jie |
|
|
37 |
3 |
p. 403-419.e6 |
artikel |
10 |
It’s All About MEis: Menin-MLL Inhibition Eradicates NPM1-Mutated and MLL-Rearranged Acute Leukemias in Mice
|
Gundry, Michael C. |
|
|
37 |
3 |
p. 267-269 |
artikel |
11 |
m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer
|
Huang, Huilin |
|
|
37 |
3 |
p. 270-288 |
artikel |
12 |
Mutant ACVR1 Arrests Glial Cell Differentiation to Drive Tumorigenesis in Pediatric Gliomas
|
Fortin, Jerome |
|
|
37 |
3 |
p. 308-323.e12 |
artikel |
13 |
Neurofibromin Is an Estrogen Receptor-α Transcriptional Co-repressor in Breast Cancer
|
Zheng, Ze-Yi |
|
|
37 |
3 |
p. 387-402.e7 |
artikel |
14 |
Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity
|
Robichaux, Jacqulyne P. |
|
|
37 |
3 |
p. 420 |
artikel |
15 |
Proteome Instability Is a Therapeutic Vulnerability in Mismatch Repair-Deficient Cancer
|
McGrail, Daniel J. |
|
|
37 |
3 |
p. 371-386.e12 |
artikel |